GCCs in Bangalore Reshaping Pharma & Biotechnology

Captive centers are offshore subsidiaries of organizations set up in locations with highly favourable business environments. The ones in Bangalore, especially for pharma and biotechnology, provide exceptionally trained employees, supportive infrastructure, data-driven solutions, and powerful compliance to foreign companies. This city also has a strategic benefit due to numerous incubation centers, research institutions, and life science clusters.

Captive centers, also known as global capability centers (GCCs), typically offer a completely parent company-owned and operated model without dependency on a third-party vendor. This ensures organizations have a greater control over assets and IP which is particularly important for healthcare companies dealing with sensitive data.

This article gives you a detailed look into how GCCs in Bangalore are offering superior R&D in pharma and biotechnology capabilities to meet the evolving market demands.

How Does Captive Centers Fuel Research & Development ?

R&D is the backbone of pharmaceutical and biotechnology industries to propel medical advancements and discovery of life-saving drugs. The process is also extremely necessary to address unmet patient needs, improve medical access, and deal with complex conditions. Below is a look into how captive centers in India, especially in Bangalore are propelling pre-clinical and clinical trials along with ensuring safety, efficacy, and regulatory compliance.

Drug Discovery

Captive centers in India, especially the ones in Bangalore, offer significant support in early-stage drug discovery along with partnerships in supply chain innovation and manufacturing analytics. For instance, Novo Nordisk gives credit to its Indian GCC for the development of its revolutionary drug Ozempic for managing diabetes. The center in Bangalore collaborated closely for clinical trials, data management, and biostatistics

GCCs like these typically tap into Big Data Analytics and Bioinformatics for the following with AI-based safety databases:

- boost drug repurposing
- identify adverse drug reactions (ADRs).

Drug design, clinical trial insights, efficacy of drug distribution, and integration of CRISPR-based genetic treatments are other most prominent ways in which global capability centers are assisting in drug discovery. AI-powered molecule identification, high-throughput screening, and computational modeling are other futuristic processes of drug discovery where R&D centers of GCCs play a distinct role thus shaping the future of healthcare innovation.

https://inductusgcc.com/wp-content/uploads/2025/03/With-870-GCCs-accounting-Image.jpg

Clinical Research & Trials

Bangalore has emerged as the hub for global innovation centers for clinical research and trials. The GCCs in the ‘Silicon Valley of India’ is playing a crucial role in clinical data management, drug development trials, and adhering to regulatory compliance associated with these processes. Presence of a strong research ecosystem with centers like IISc, IBAB, and NIMHANS are powering trial efficiencies and drug discovery. The key areas where GCCs in Bangalore are ahead of competitors are:

- Trial documentation and benefit analysis of new drugs.
- Pharmacovigilance and adverse drug event reporting.
- Creating research papers and their patent filings.
- Predicting patient responses and trial outcomes with ML.

Further, these GCCs also help with biosimilar development, medical writing, and contract research. Altogether, this makes Bangalore rise as the Pharma powerhouse on a global scale.

Treatment & Therapy Innovation

GCCs in Bangalore have specialized focus on cell therapies, gene therapies, and biosimilars for innovative diagnostics and treatment development. Partnering with research labs and academic institutions and workers in different parts of Bangalore serve as a catalyst for innovation and drug pipeline acceleration.

But how exactly are these made possible? Well, these offshore development centers maximize artificial intelligence, Big Data, IoT, machine learning, and genomics. Besides the above-mentioned benefits, these also help with developing targeted therapies for life-threatening diseases like cancer. Lastly, these centers significantly contribute in mRNA-based vaccine research, epidemiology studies, and biologics.

Emerging Health Threats

A critical role of GCCs in pharma and biotechnology is dealing with potential health threats by supporting R&D in similar lines. Top medical companies can trust their offshore captive development centers with vaccine research, trials, and large-scale production. They can also make the most of machine learning and predictive analytics to research mutation trends, pandemic patterns, and disease outbreaks in real-time.

Further,GCCs have decentralized clinical trials (DCTs) in place to increase time-to-market for critical medicines. They collaborate with research centers, government bodies, and health organizations to help their parent companies launch global health solutions for antimicrobial resistance and to curb infectious diseases.

https://inductusgcc.com/wp-content/uploads/2025/03/In-a-world-full-of-rapid-Quote.jpg

Top 3 Pharma Companies with GCCs in Bangalore

Below are several leading pharmaceutical organizations that have leveraged the rich talent pool and business ecosystem of Bangalore to set up a GCC. Here’s a quick glance.

- Eli Lilly: This is an Indian pharma company which has a well-operational GCC in Bangalore since 2016 called the Lilly Capability Center to supercharge its drug development prowess. Given the business boom, it is doubling its presence in northern Hyderabad in 2025.
- Biogen: BCCI or The Biogen Capability Center India in Bangalore supports the development of different therapies for businesses worldwide.
- Novo Nordisk: The GCC of this Danish pharmaceutical company in Bangalore has continually contributed to research and development of drugs like Ozempic.

Beyond Innovation: Regulatory Compliance in GCCs

Global capability centers conduct in-depth research and development to ensure pharmaceutical products of their parent organizations strictly meet HIPAA in the US and GDPR in Europe. Further, they also ensure compliance with FDA, ICH, EMA, CDSCO global regulatory standards. These are extremely critical to safeguard patient data and ensure public trust. Otherwise, severe fines are levied along with reputational damage which impacts businesses.

With this, GCCs have successfully established themselves as a microcosm of their parent organizations in terms of robust R&D and the related services.

Conclusion

Indian GCCs, especially the ones established in Bangalore, offer strategic cross-functional services, especially robust R&D to increase competitiveness, innovation, and long-term growth. Previously, captive centers were set up to support IT, legal, finance and similar processes. Today, they have evolved into transformative hubs for hardcore research, development and innovation to drive efficiency and business continuity. In the near future, decentralized research models and virtual clinical trials are expected to be the new reality in GCCs.

https://inductusgcc.com/wp-content/uploads/2025/03/Unlock-your-RD-CTA.jpg

Therefore, it is a good idea to partner with a trusted GCC enabler like Inductus GCC which could be a game-changer for your R&D initiatives. We have a strong network of industry partnerships that drives transformational outcomes. The team is specialized in specific fields of their parent companies like biotechnology and pharmaceuticals to help you reach from just an idea to a powerful global impact. Rest assured, it is a worthy investment to catalyze innovation and maintain a competitive benefit in the market.